Departed
(interim)
Yumin Liu
Chief Executive Officer
Emeren Group Ltd
Mr. Yumin Liu, Chief Executive Officer (“CEO”), will step down from his role effective April 30, 2025.
Executive movement radar
Recent machine-extracted executive movements from SEC 8-K Item 5.02 filings, source-linked. Every card cites the SEC source.
Showing 3051–3100 of 75356
Departed
Christine Pambianchi
director
MBLY ·
Mobileye Global Inc.
On April 2, 2025, Ms. Christine Pambianchi informed Mobileye Global Inc. (the “Company”) of her resignation from the board of directors (the “Board”), effective April 25, 2025 in connection with her resignation as executive vice president and chief people officer of Intel Corporation, the Company’s controlling shareholder.
Departed
Bob Hurst
Director
VCTR ·
Victory Capital Holdings, Inc.
The Company announced that Bob Hurst, one of Crestview Partners’ nominees on the Company’s board of directors (the “Board”), retired from the Board effective as of April 1, 2025
Departed
Kevin O’Boyle
Director
NEVRO CORP
each of the directors of Nevro (D. Keith Grossman, Michael DeMane, Kirt Karros, Sri Kosaraju, Shawn T. McCormick, Kevin O’Boyle, Karen N. Prange, Susan Siegel, Kevin Thornal and Elizabeth Weatherman) resigned from the Board.
Departed
Karen N. Prange
Director
NEVRO CORP
each of the directors of Nevro (D. Keith Grossman, Michael DeMane, Kirt Karros, Sri Kosaraju, Shawn T. McCormick, Kevin O’Boyle, Karen N. Prange, Susan Siegel, Kevin Thornal and Elizabeth Weatherman) resigned from the Board.
Departed
Sri Kosaraju
Director
NEVRO CORP
each of the directors of Nevro (D. Keith Grossman, Michael DeMane, Kirt Karros, Sri Kosaraju, Shawn T. McCormick, Kevin O’Boyle, Karen N. Prange, Susan Siegel, Kevin Thornal and Elizabeth Weatherman) resigned from the Board.
Departed
Kevin Thornal
Director
NEVRO CORP
each of the directors of Nevro (D. Keith Grossman, Michael DeMane, Kirt Karros, Sri Kosaraju, Shawn T. McCormick, Kevin O’Boyle, Karen N. Prange, Susan Siegel, Kevin Thornal and Elizabeth Weatherman) resigned from the Board.
Departed
Shawn T. McCormick
Director
NEVRO CORP
each of the directors of Nevro (D. Keith Grossman, Michael DeMane, Kirt Karros, Sri Kosaraju, Shawn T. McCormick, Kevin O’Boyle, Karen N. Prange, Susan Siegel, Kevin Thornal and Elizabeth Weatherman) resigned from the Board.
Departed
Michael DeMane
Director
NEVRO CORP
each of the directors of Nevro (D. Keith Grossman, Michael DeMane, Kirt Karros, Sri Kosaraju, Shawn T. McCormick, Kevin O’Boyle, Karen N. Prange, Susan Siegel, Kevin Thornal and Elizabeth Weatherman) resigned from the Board.
Departed
Kirt Karros
Director
NEVRO CORP
each of the directors of Nevro (D. Keith Grossman, Michael DeMane, Kirt Karros, Sri Kosaraju, Shawn T. McCormick, Kevin O’Boyle, Karen N. Prange, Susan Siegel, Kevin Thornal and Elizabeth Weatherman) resigned from the Board.
Departed
D. Keith Grossman
Director
NEVRO CORP
each of the directors of Nevro (D. Keith Grossman, Michael DeMane, Kirt Karros, Sri Kosaraju, Shawn T. McCormick, Kevin O’Boyle, Karen N. Prange, Susan Siegel, Kevin Thornal and Elizabeth Weatherman) resigned from the Board.
Departed
Susan Siegel
Director
NEVRO CORP
each of the directors of Nevro (D. Keith Grossman, Michael DeMane, Kirt Karros, Sri Kosaraju, Shawn T. McCormick, Kevin O’Boyle, Karen N. Prange, Susan Siegel, Kevin Thornal and Elizabeth Weatherman) resigned from the Board.
Departed
Elizabeth Weatherman
Director
NEVRO CORP
each of the directors of Nevro (D. Keith Grossman, Michael DeMane, Kirt Karros, Sri Kosaraju, Shawn T. McCormick, Kevin O’Boyle, Karen N. Prange, Susan Siegel, Kevin Thornal and Elizabeth Weatherman) resigned from the Board.
Departed
Eyal C. Attar, M.D.
Chief Medical Officer
VOR ·
Vor Biopharma Inc.
On March 31, 2025, Eyal C. Attar, M.D., notified Vor Biopharma Inc. (the “Company”) of his decision to resign as Chief Medical Officer of the Company, effective as of April 18, 2025, in order to pursue a new opportunity.
Departed
Andrew Mercieca
Vice President of Finance and principal accounting officer
AUTL ·
Autolus Therapeutics plc
On February 24, 2025, Andrew Mercieca notified Autolus Therapeutics plc (the “Company”) of his intention to resign from his role as the Company’s Vice President of Finance and principal accounting officer, to pursue another opportunity.
Departed
Donna L. DeCarolis
President of National Fuel Gas Distribution Corporation
NFG ·
NATIONAL FUEL GAS CO
On March 31, 2025, Donna L. DeCarolis, President of National Fuel Gas Distribution Corporation, provided notice to National Fuel Gas Company of her intention to retire, effective July 1, 2025.
Departed
Beth Pritchard
Director
ELF ·
e.l.f. Beauty, Inc.
On March 31, 2025, Beth Pritchard notified e.l.f. Beauty, Inc. (the “ Company ”) of her decision to resign from the Company’s Board of Directors (the “ Board ”) and all committees thereof, effective March 31, 2025.
Departed
Derek V. Brummer
President, Mortgage Insurance
RDN ·
RADIAN GROUP INC
On March 28, 2025, the Company and Mr. Brummer agreed to accelerate the date of Mr. Brummer’s retirement from his current role to April 21, 2025.
Departed
Robert E. Grove
Director
IRIX ·
IRIDEX CORP
Robert E. Grove has agreed to resign and has submitted his resignation to the Company’s Board and all committees thereof, effective as of April 2, 2025.
Departed
Todd W. Arden
director
QMCO ·
QUANTUM CORP /DE/
Effective April 2, 2025, Todd W. Arden, a member of the Board, informed the Company of his decision to resign from the Board.
Departed
James Sapirstein
Executive Chairman
ONCO ·
Onconetix, Inc.
Effective as of March 28, 2025, James Sapirstein resigned as Executive Chairman and a member of the Board of Directors (the “Board”) of Onconetix, Inc. (the “Company”).
Departed
Roman Tkachenko
Director
4Front Ventures Corp.
On March 29, 2025, Chetan Gulati, Leo Gontmakher, and Roman Tkachenko resigned from the Board of Directors of 4Front Ventures Corp.
Departed
Chetan Gulati
Director
4Front Ventures Corp.
On March 29, 2025, Chetan Gulati, Leo Gontmakher, and Roman Tkachenko resigned from the Board of Directors of 4Front Ventures Corp.
Departed
Leo Gontmakher
Director
4Front Ventures Corp.
On March 29, 2025, Chetan Gulati, Leo Gontmakher, and Roman Tkachenko resigned from the Board of Directors of 4Front Ventures Corp.
Departed
Clark Callandar
Class I member of the Board of Directors
SLE ·
Super League Enterprise, Inc.
Effective March 31, 2025, Clark Callandar resigned as a Class I member of the Board of Directors of the Company.
Departed
Karen Sims
Chief Medical Officer
ABUS ·
Arbutus Biopharma Corp
the Company terminated, without cause, Karen Sims, M.D., Ph.D. as Chief Medical Officer of the Company, effective March 25, 2025.
Departed
David Hastings
Chief Financial Officer
ABUS ·
Arbutus Biopharma Corp
the Company terminated, without cause, David Hastings as Chief Financial Officer of the Company, effective as of the end of the day on March 27, 2025.
Departed
Robert Synowicki, Jr.
Director
KNX ·
Knight-Swift Transportation Holdings Inc.
On April 1, 2025, Robert Synowicki, Jr. confirmed to Knight-Swift Transportation Holdings Inc. (the "Company") that he will not be standing for reelection at the Company’s 2025 Annual Meeting of Stockholders.
Departed
Mark Mason
Chairman, Chief Executive Officer and President
MCHB ·
Mechanics Bancorp
HomeStreet and Mechanics Bank entered into a consulting agreement (the “ Consulting Agreement ”) with Mark Mason, the Chairman, Chief Executive Officer and President of HomeStreet, pursuant to which Mr. Mason’s employment with HomeStreet and HomeStreet Bank will terminate on the first day following the closing of the Merger
Departed
Thomas J. DeRosa
Director
ESRT ·
Empire State Realty Trust, Inc.
Thomas J. DeRosa, a member of the board of directors (the “Board”), Chair of the Compensation Committee and a member of the Audit Committee of Empire State Realty Trust, Inc. (the “Company”), notified the Company of his intention to retire and not stand for re-election to the Board at the Company’s 2025 Annual Meeting of Shareholders, currently expected to be held on May 15, 2025 (the “Annual Meeting”).
Departed
C. Robert Kehler
Director
ASLE ·
AerSale Corp
each of Peter Nolan and General C. Robert Kehler notified the Company of their intent not to stand for re-election as a member of the Board at the 2025 Annual Meeting
Departed
Peter Nolan
Director
ASLE ·
AerSale Corp
each of Peter Nolan and General C. Robert Kehler notified the Company of their intent not to stand for re-election as a member of the Board at the 2025 Annual Meeting
Departed
Alexander Baum
Director
NSIT ·
INSIGHT ENTERPRISES INC
On March 28, 2025, Alexander Baum notified the Board of Directors (the “Board”) of Insight Enterprises, Inc. (the “Company”) that he intends to retire from the Board and will not stand for election at the Company’s next annual meeting of stockholders (the “2025 Annual Meeting”).
Departed
Anthony Kerrigone
officer and director
BLNH ·
Blue Line Holdings, Inc.
Following the appointment of Mr. Henn as an officer and director, Anthony Kerrigone resigned as an officer and director of the Company.
Departed
William Myrick
Partner
Shepherd's Finance, LLC
On March 31, 2025, William Myrick was terminated from his position as the Partner of Shepherd’s Finance, LLC (the “Company”) without cause.
Departed
Aurora Cassirer
Director
FEED ·
ENvue Medical, Inc.
On April 1, 2025, Aurora Cassirer submitted her resignation as a member of the board of directors of NanoVibronix, Inc. (the “Company”), which resignation became effective immediately.
Departed
Darren W. Spriggs
Chief Financial Officer, Treasurer, and Corporate Secretary
ENGLOBAL CORP
On April 1, 2025, Darren W. Spriggs resigned as Chief Financial Officer, Treasurer, and Corporate Secretary of ENGlobal Corporation (the “Company”).
Departed
Khachactur Mkrtchyan
Chairman, President, Chief Executive Officer
LEGEND SPICES, INC.
As of March 29, 2025, Khachactur Mkrtchyan, the Chairman, President, Chief Executive Officer, (Principal Executive Officer, Principal Financial Officer and Principal Accounting Officer) of Legend Spices, Inc. (the “Company”), is no longer holding the positions.
Departed
Judy Su
member of the Board of Directors
Virpax Pharmaceuticals, Inc.
On April 2, 2025, Esha Randhawa, Charn Deol, and Judy Su each resigned from their positions as members of the Board of Directors of the Company, effective immediately.
Departed
Charn Deol
member of the Board of Directors
Virpax Pharmaceuticals, Inc.
On April 2, 2025, Esha Randhawa, Charn Deol, and Judy Su each resigned from their positions as members of the Board of Directors of the Company, effective immediately.
Departed
Usama Chaudhry
Chief Financial Officer
Virpax Pharmaceuticals, Inc.
On the same date, Usama Chaudhry resigned from his position as Chief Financial Officer of the Company, effective immediately.
Departed
Esha Randhawa
member of the Board of Directors
Virpax Pharmaceuticals, Inc.
On April 2, 2025, Esha Randhawa, Charn Deol, and Judy Su each resigned from their positions as members of the Board of Directors of the Company, effective immediately.
Departed
Esha Randhawa
Member of the Board of Directors
Virpax Pharmaceuticals, Inc.
On April 2, 2025, Esha Randhawa, Charn Deol, Judy Su, and Katharyn Field each resigned from their positions as members of the Board of Directors of the Company, effective immediately.
Departed
Usama Chaudhry
Chief Financial Officer
Virpax Pharmaceuticals, Inc.
On the same date, Ms. Field also resigned from her position as Vice President, and Usama Chaudhry resigned from his position as Chief Financial Officer of the Company, each effective immediately.
Departed
Judy Su
Member of the Board of Directors
Virpax Pharmaceuticals, Inc.
On April 2, 2025, Esha Randhawa, Charn Deol, Judy Su, and Katharyn Field each resigned from their positions as members of the Board of Directors of the Company, effective immediately.
Departed
Charn Deol
Member of the Board of Directors
Virpax Pharmaceuticals, Inc.
On April 2, 2025, Esha Randhawa, Charn Deol, Judy Su, and Katharyn Field each resigned from their positions as members of the Board of Directors of the Company, effective immediately.
Departed
Katharyn Field
Vice President
Virpax Pharmaceuticals, Inc.
On the same date, Ms. Field also resigned from her position as Vice President, and Usama Chaudhry resigned from his position as Chief Financial Officer of the Company, each effective immediately.
Departed
Katharyn Field
Member of the Board of Directors
Virpax Pharmaceuticals, Inc.
On April 2, 2025, Esha Randhawa, Charn Deol, Judy Su, and Katharyn Field each resigned from their positions as members of the Board of Directors of the Company, effective immediately.
Departed
Paul Frenkiel
Executive Vice President, Chief Financial Officer and Secretary
TBBK ·
Bancorp, Inc.
On March 28, 2025, Paul Frenkiel, 72, announced his retirement from his position as the Executive Vice President, Chief Financial Officer and Secretary of The Bancorp, Inc.
Departed
Scott Peak
Board of Directors
LNG ·
Cheniere Energy, Inc.
In connection with the appointment of Mr. Runkle and pursuant to the terms of the Agreement, Scott Peak resigned from the Board on April 1, 2025.
Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.